A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Name: A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
Published: 1997
License: Public Domain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 1997

ClinicalTrials.gov · Datasets · License: Public Domain · 1997

Open Source ↗

alzheimer-disease alzheimer-s-disease caregiver dementia placebo quality-of-life

alzheimer disease, dementia, alzheimer's disease, brain disease, memory loss, galantamine, placebo, caregiver, quality of life, resource utilization, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Related documents